The influence of CD137 signaling on the expression of NFATc1 through TRAF6 and NF-κB p65 may have extensive implications for the diagnosis and therapeutic intervention for a variety of proliferative cardiovascular diseases. The gene discussed is NFATC1; the disease is cardiovascular disorder.